Icahn School of Medicine at Mount Sinai
1425 Madison Avenue, L14-52A
New York
NY
10029
United States
Tel: 917742-8019
29 articles with Icahn School of Medicine at Mount Sinai
-
Rensselaer Polytechnic Institute and Icahn School of Medicine at Mount Sinai Announce Joint Center for Engineering and Precision Medicine
5/31/2022
Rensselaer Polytechnic Institute and the Icahn School of Medicine at Mount Sinai recently announced the creation of the Center for Engineering and Precision Medicine, one of the first centers in the nation to bridge engineering and engineering science with medicine.
-
Protagonist Therapeutics' Phase II study of an ulcerative colitis treatment failed to meet its primary endpoint at a higher dosage amount. Even so, the company remains optimistic about the drug's future.
-
A team of scientists from Mount Sinai was able to uncover specific tumor microenvironment (TME) regulators using a novel functional genomics technology known as Perturb-map.
-
Rockley Photonics Unveils Collaborative Clinical Research Initiative for Remote Patient Monitoring and Diagnosis
11/18/2021
Rockley Photonics, a global leader in photonics-based health monitoring and communications solutions, formed a strategic relationship to incorporate Rockley’s non-invasive biomarker sensing platform into potential clinical and healthcare research studies.
-
Mount Sinai Spin-Off Linus Biotechnology Inc. to Revolutionize Precision Medicine with Exposome Sequencing
11/17/2021
Linus Biotechnology Inc. and Mount Sinai Innovation Partners announced an exclusive worldwide license and collaboration agreement in progress with the Icahn School of Medicine at Mount Sinai, the medical school of the Mount Sinai Health System.
-
The NIH revealed that bumetanide, a drug typically used as a diuretic, maybe a potential treatment for those genetically at risk for Alzheimer's. Know more about it here.
-
Research shows that cancer can fool immune cells, which normally repair the body, into actually helping develop the disease.
-
New Life-Changing Test for Patients Diagnosed With Peanut Allergy
6/15/2021
AllerGenis announced the publication of a peer-reviewed study entitled, "Accurate and Reproducible Diagnosis of Peanut Allergy Using Epitope Mapping." Conducted by leading global experts in pediatric allergy and immunology from the Icahn School of Medicine at Mount Sinai, Stanford University and Kings College, the study found the AllerGenis peanut diagnostic blood test demonstrates accuracy significantly and statistically superior to all other established diagnostic tests.
-
Researchers at multiple companies and institutes are doggedly pursuing clinical programs so the virus can become little more than a hindrance in the future.
-
AMSURG and Mount Sinai Health System Release New Research on Early-Onset Colorectal Cancer
5/24/2021
AMSURG, a division of Envision Healthcare and a national leader in outpatient care, and Icahn School of Medicine at Mount Sinai, world-renowned for its groundbreaking research, released new findings on colorectal cancer (CRC)
-
A recent Phase II trial show Regeneron’s monoclonal antibody evinacumab significantly reduced fasting triglycerides in patients with severe hypertriglyceridemia.
-
Lactiga Announces NIH-Funded Partnership with Mount Sinai to Advance its Patented Biologic for COVID-19 Treatment
10/14/2020
Lactiga Inc., a biotechnology company advancing its patented anti-infective biologic, LCTG-001, announced today a collaboration agreement with the Icahn School of Medicine at Mount Sinai to advance preclinical research into LCTG-001 as a potential treatment for COVID-19 patients. The collaborative team, led by Dr. Rebecca Powell, Assistant Professor of Medicine (Infectious Diseases), secured an NIH R01 Emergency Award of
-
Dynavax and Mount Sinai Announce Collaboration to Develop a Universal Influenza Vaccine Candidate with CpG 1018 Adjuvant
7/16/2020
Development funded under contract award from NIAID/NIH as part of the CIVICs program Currently no approved universal influenza vaccine CDC estimates 35.5 million people were infected with influenza in U.S. during 2018-2019 season Collaboration will combine Dynavax’s CpG 1018 with influenza antigens designed to protect against all strains of influenza NEW YORK and EMERYVILLE, Calif., July 16, 2020 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX), a biopharmaceutical c
-
The Elie Hirschfeld Foundation Makes New Contributions for Research and to Combat Coronavirus in New York
3/13/2020
The Elie Hirschfeld Foundation announces a multi-faceted effort to aid the region's response to the rapidly growing crisis created by the novel Coronavirus COVID-19.
-
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
Scientists Identify Differences Between Relapsing/Remitting and Progressive Multiple Sclerosis
7/16/2019
Multiple sclerosis (MS) is an often-disabling disease of the central nervous system caused by damage to the myelin coating around the nerves. -
Research Roundup for Friday, May 24.
-
New data on sepsis outcomes in hospitals shows how fatalities can be reduced
4/24/2019
The findings first appeared on April 8 in the Journal of Hospital Medicine, the official peer-reviewed journal of the Society of Hospital Medicine.
-
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.